April 23, 2014 10:13 PM ET

Healthcare Equipment and Supplies

Company Overview of TransMedics, Inc.

Company Overview

TransMedics, Inc. develops living organ transplant systems. It offers TransMedics Organ Care System, a portable warm blood perfusion system, designed to maintain organs in a warm and functioning state outside the human body during transport from organ donor to recipient. The company’s products are used in heart, lung, liver, and kidney transplants. It serves hospitals and clinicians, patients and families, donor organizations, and insurers and payors. The company markets and sells its products in the United States, the European Union, Asia, and the Middle East. TransMedics was founded in 1998 and is headquartered in Andover, Massachusetts.

200 Minuteman Road

Suite 302

Andover, MA 01810

United States

Founded in 1998

93 Employees

Phone:

978-552-0900

Fax:

978-685-9562

Key Executives for TransMedics, Inc.

Founder
Age: 45
Chief Financial Officer and Treasurer
Age: 40
Vice President of Operations
Age: 50
Chief Medical Officer
Age: 44
Director of IP & In-house Counsel
Compensation as of Fiscal Year 2013.

TransMedics, Inc. Key Developments

TransMedics, Inc. Announces Final Results of The PROCEED II Heart FDA Pivotal Trial at ISHLT

TransMedics, Inc. announced that the PROCEED II heart transplant Food and Drug Administration pivotal trial results using the Organ Care System - Heart platform were announced on Saturday, April 12, 2014 at the International Society for Heart and Lung Transplantation 34th Annual Meeting and Scientific Sessions in San Diego, Calif. The OCS Heart PROCEED II FDA pivotal trial met its success criteria for both the primary effectiveness and safety endpoints by demonstrating that the OCS is as safe and effective as the current standard of care (SOC) in preserving standard donor hearts for transplantation. These results were achieved despite the OCS arm having significantly longer total cross clamp time as compared to SOC. In addition, the data from PROCEED II Trial demonstrated that circulating lactate level of the OCS perfusion could be a useful parameter to evaluate donor hearts status ex-vivo.

TransMedics, Inc. Appoints Jeffrey E. Young as Chief Financial Officer and Treasurer

TransMedics, Inc. announced that Jeffrey E. Young was appointed to the position of Chief Financial Officer and Treasurer, effective August 2013. Mr. Young responsible for the company's finance, accounting, and treasury functions and reports directly to Waleed Hassanein, M.D., President and Chief Executive Officer of the company. During his career, Mr. Young has held a variety of senior executive roles in the life sciences industry. From 2008 to 2013, Mr. Young served in a number of senior executive roles at Lantheus Medical Imaging, including Chief Financial Officer from 2012 to 2013. Prior to his time with Lantheus, Mr. Young spent three years at Critical Therapeutics, Inc. Prior to 2005, he served in a number of roles at PerkinElmer, Inc.

TransMedics, Inc. Announces Board Appointments

David Abrams, Managing Member of Abrams Capital and Travis Rhodes, Managing Director at Abrams Capital both have joined TransMedics’ Board of Directors.

Similar Private Companies By Industry

Company Name Region
Xi Tec, Inc. United States
Physio-Control International, Inc. United States
AngioLight Inc United States
International Cardio Corporation United States
OptoSigma Corporation United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
June 13, 2013
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TransMedics, Inc., please visit www.transmedics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.